We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Ever since last November, when Bayer ended months of speculation and confirmed it would be casting off its animal health unit, investors have been waiting for details.